Related Experiment Videos

BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization

Salvatore C Ruffolo1, Gordon C Shore

  • 1Department of Biochemistry, McGill University, Montreal, Quebec H3G 1Y6, Canada.

Insights

BCL-2 protein inhibits apoptosis by blocking BAK activation. Excess BCL-2 sequesters activated BAK, preventing cytochrome c release and cell death, even when BID initiates BAK opening.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Caspase-8 initiates apoptosis by cleaving BID to tBID.
  • tBID targets mitochondria, inducing BAX and BAK oligomerization and cytochrome c release.

Purpose of the Study:

  • To investigate the mechanism of BCL-2 in inhibiting apoptosis.
  • To analyze the interaction between BID BH3, BAK, and BCL-2 in isolated mitochondria and intact cells.

Main Methods:

  • Isolated mitochondria from control and BCL-2-overexpressing cells were used.
  • Synthetic BH3 peptides initiated apoptosis-related events.
  • Chemical cross-linking analyzed BCL members' interactions.

Main Results:

  • BID BH3 domain induces an "open" conformation of BAK, exposing its N terminus.
  • This activated BAK triggers a cascade of auto-oligomerization.
  • BCL-2 selectively binds to activated BAK, blocking oligomerization and cytochrome c release, dependent on BCL-2 and BID BH3 ratio.

Conclusions:

  • BCL-2's primary inhibition mechanism targets activated BAK, not tBID.
  • Excess BCL-2 effectively sequesters activated BAK, halting downstream apoptotic events.
  • This mechanism is validated in both isolated mitochondria and intact cells stimulated with Fas or expressing tBID.

Related Concept Videos